Published:
BIOLASE Receives New U.S. Patent for Electromagnetic Cleaning and Whitening Toothbrush System
BIOLASE Receives New U.S. Patent for Electromagnetic Cleaning and Whitening Toothbrush System
Patent for Energy Emitting Toothbrush Combined With Photosensitive Dentifrice Bolsters Intellectual Property, Business Development in Consumer Markets
BIOLASE Technology, Inc. (NASDAQ: BLTI), the
world's leading dental laser company, announced today that it has been
granted a new U.S. patent related to its oral care technologies for a teeth
cleaning and whitening system using a toothbrush that emits electromagnetic
energy combined with a dentifrice containing a photosensitive agent.
President and CEO Jeffrey W. Jones said that this new patent strengthens
the Company's protection for a variety of innovative consumer products
either under consideration or already in development.
"Our overall business strategy includes pursuing the development of
consumer products based upon our core technologies and related intellectual
property portfolio. This patent and others that are pending add to our
already solid position for future product development in this category,"
Jones added.
The patent, No. 7,261,558, granted by the U.S. Patent and Trademark Office,
contains both device and method claims related to a cleaning and whitening
system for teeth, comprised of a toothbrush having a cleaning surface that
incorporates a source of electromagnetic radiation (energy) that focuses
energy toward the cleaning surface during brushing to enhance cleaning of
the teeth and a dentifrice that disperses a photosensitive agent including
a whitening compound. The patent contains 147 claims, of which seven are
independent.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading
dental laser company, is a medical technology company that develops,
manufactures and markets lasers and related products focused on
technologies that advance the practice of dentistry and medicine. The
Company's products incorporate patented and patent pending technologies
designed to provide clinically superior performance with less pain and
faster recovery times. BIOLASE's principal products are dental laser
systems that perform a broad range of dental procedures, including cosmetic
and complex surgical applications. Other products under development address
ophthalmology and other medical and consumer markets.
This press release may contain forward-looking statements within the
meaning of safe harbor provided by the Securities Reform Act of 1995 that
are based on the current expectations and estimates by our management.
These forward-looking statements can be identified through the use of words
such as "anticipates," "expects," "intends," "plans," "believes," "seeks,"
"estimates," "may," "will," and variations of these words or similar
expressions. Forward-looking statements are based on management's current,
preliminary expectations and are subject to risks, uncertainties and other
factors which may cause the Company's actual results to differ materially
from the statements contained herein, and are described in the Company's
reports it files with the Securities and Exchange Commission, including its
annual and quarterly reports. No undue reliance should be placed on
forward-looking statements. Such information is subject to change, and we
undertake no obligation to update such statements.
Copyright © 2008, MarketWire
Copyright © 2008, NewsBlaze,
Daily NewsTags: Tags: Pharmaceuticals, california,
_ _
Search News
Daily News
